ABRE Study - 36-month clinical outcomes

The ABRE Study shows clinically meaningful impact on quality of life through 36 months — even in the most complex patients.

Review cinical outcomes


categorized as PTS patients


of PTS patients presented with complete vein occlusion

112.4 mm

average lesion length


patients with stents extending below inguinal ligament

Graph - 16.6% aDVT patients
Graph - 47.5% PTS patients
Graph - 36% NVL patients

Site and core lab data were used.
Source: Abre stent IFU.

See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.


© 2023 Medtronic. All rights reserved. UC202403554-cirse-2023-post-congress-eblast-for-abre-en-emea-10231629